Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Herzig

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Cancer|May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantationH M Lazarus, M R Gottfried, R H Herzig, et al.
Blood|April 1, 1991
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adultsG L Phillips, D E Reece, J D Shepherd, et al.
Blood|January 11, 2000
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registryS Giralt, R Szydlo, J M Goldman, et al.
Bone Marrow Transplantation|May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant GroupS N Wolff, J Fay, D Stevens, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation|January 1, 1996
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemiaC Rozman, E Carreras, C Qian, et al.
Bone Marrow Transplantation|March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemiaJ R Passweg, P Tiberghien, J Y Cahn, et al.
Leukemia|November 1, 1996
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remissionR P Gale, T Büchner, M J Zhang, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Cancer|May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantationH M Lazarus, M R Gottfried, R H Herzig, et al.
Blood|April 1, 1991
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adultsG L Phillips, D E Reece, J D Shepherd, et al.
Blood|January 11, 2000
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registryS Giralt, R Szydlo, J M Goldman, et al.
Bone Marrow Transplantation|May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant GroupS N Wolff, J Fay, D Stevens, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation|January 1, 1996
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemiaC Rozman, E Carreras, C Qian, et al.
Bone Marrow Transplantation|March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemiaJ R Passweg, P Tiberghien, J Y Cahn, et al.
Leukemia|November 1, 1996
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remissionR P Gale, T Büchner, M J Zhang, et al.
Pageof 10